Market Overview

Barclays Maintains Hospira at Underweight, Lowers PT from $36 to $34

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Price Target Analyst Ratings

 

Most Popular

Related Articles (HSP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free